Phase 1 Safety and PK Study of OLT1177 Capsules
NCT02134964
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
OLT1177 Capsules
DRUG:
Placebo Capsules
Sponsor
Olatec Therapeutics LLC